Cantillano-Rodríguez SN, Chávez E, Meza R, Ochoa A

Language: Spanish
References: 18
Page: 855-863
PDF size: 442.01 Kb.

ABSTRACT

Background: Ambulatory blood pressure monitoring (ABPM) more accurately predicts the risk of cardiovascular complications than blood pressure in the office. The ABPM parameter that is associated most closely is the average nighttime blood pressure.
Objective: To determine the prevalence and factors associated of alterations in the ABPM parameters of 24 hours in diabetic patients.
Material and Method: A descriptive, cross-sectional study was done from January to June 2017 in patients with type 2 diabetes mellitus with or without a history of arterial hypertension. A clinical and laboratory evaluation was carried out to identify cardiovascular risk factors. For ABPM, Watch BP 03 monitors were used.
Results: 127 patients were included. 24-hours hypertension was found in 46.5% and daytime hypertension in 35.4%. The prevalence of nocturnal hypertension was 66.1% and of isolated nocturnal hypertension of 32.3%. The prevalence of non-dipper pattern was 49.6%, Riser pattern 24.4%, Dipper 22.8% and extreme Dipper 3.1%. The factors significantly associated with the presence of nocturnal hypertension were smoking, time of evolution of diabetes mellitus, age and serum creatinine concentration.
Conclusions: A high prevalence of nocturnal alterations in blood pressure was found.

REFERENCES

1. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006;354:2368-74.

2. Gorostidi M, Segura J, De la Sierra A. Hipertensión arterial nocturna. Hipertension. Hipertens Riesg Vasc 2010;27(supl 1):26-33.

3. Clement DL, de Buyzere ML, de Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003;348:2407-15.

4. Hermida RC, Ayala DE, Mojón A, Fernández JR. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol 2011;58:1165-73.

5. Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz J, et al. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens 2008;21:443-50.

6. Hermida RC, Ayala DE, Mojón A, Fernández JR. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am J Hypertens 2012;25:325-34.

7. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension 2005;46:156-61.

8. Hermida RC, Ayala DE, Fernández JR, Mojón A. Sleep-time blood pressure: Prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int 2013;30:68-86.

9. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, et al. Daytime and nighttime blood ressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008;51:55-61.

10. Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 2010;28:2036-45.

11. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, et al. Prognostic role of ambulatory blood pressure measurement in patients with non-dialysis chronic kidney disease. Arch Intern Med 2011;171:1090-8.

12. Gorostidi M, Sobrino J, Segura J, Sierra C, De la Sierra A, Hernández del Rey R, et al, on behalf of the Spanish Society of Hypertension ABPM Registry investigators. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20000-patient database in Spain. J Hypertens 2007;25:977-84.

13. Ramón C. Hermida, Diana E. Ayala, Artemio Mojón & José R. Fernández (2010) Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiology International 27(8):1629- 1651, DOI: 10.3109/07420528.2010.510230

14. Japanese Circulation Society. Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring. Circulation J 2016;76:508-19.

15. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HAJ, Zanchetti A. 2007 guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hipertensión of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens 2007;25:1105-1187.

16. Sierra C, De la Sierra A, Sobrino J, Segura J, Banegas JR, Gorostidi M, Ruilope LM, en representación de los Investigadores del Registro Nacional de MAPA. Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertension Arterial (SEH-LELHA). Monitorización ambulatoria de la presión arterial (MAPA): características clínicas de 31.530 pacientes incluidos en el registro. Med Clin (Barc) 2007;129:1-5.

17. De la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, et al, on behalf of the Spanish Society of Hypertension Ambulatory Blood Pressure Monitoring Registry Investigators. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 2009;53:466-72.

18. Gorostidi M, De la Sierra A, Segura J, Tranche S, López- Zuñiga MC, García-Puig J, et al, on behalf of the Spanish Society of Hypertension ABMP Registry. Prevalence of isolated nocturnal hypertension in treated hypertensives. The Spanish Society of Hypertension ABPM Registry. J Hypertens 2008;26 Suppl 1:S502-3 [abstract].